Skip to main content

ACNE VULGARIS

 Acne vulgaris

Acne vulgaris is a disorder of pilosebaceous complex which predominantly affects the peripubertal population and clinically manifests as comedones (open- blackheads, closed- whiteheads), papules, nodules, pustules and cysts and heals with scars.

Pathogenesis

1. Occlusion of pilosebaceous orifice
  • Pilosebaceous orifice in acne is occluded by a keratinous plug induced by: chemicals (cosmetics) and reduced levels of linoleic acid in sebum of acne patients.
  • Results in retention of sebum, encouraging growth of microbes, triggering a vicious cycle.
  • Distended follicle ruptures, releasing proinflammatory chemicals into the dermis, stimulating intense inflammation. 
  • Ductal epithelium also produces cytokines and an inflammatory cascade is triggered.
2. Increased sebum production
  • Sebaceous gland activity is controlled by androgens.
  • Most patients have normal levels of circulating androgens, but their sebaceous glands are unusually sensitive to androgens due to an enhanced end organ sensitivity.
  • This is due to increased activity in sebaceous glands of an enzyme 5 alpha-reductase, which converts testosterone to more potent 5 alpha-dihydrotestosterone, which binds to specific receptors in the sebaceous glands increasing sebum production.
3. Microbial colonization
  • Organisms implicated: Propionibacterium spp. especially P. acnes, Malassezia furfur, Staph epidermidis.
  • Role in pathogenesis: these organisms trigger a type 4 inflammatory response and produce extracellular enzymes, which attracts inflammatory cells.
3. Release of inflammatory mediators
  • Distended follicles ruptures, releasing inflammatory chemicals into the dermis, stimulating intense inflammation.
  • Ductal epithelium also produces cytokines, triggering an inflammatory cascade.
  • Microbes also produces extracellulae enzymes, which attract inflammatory cells.

Factors modifying acne

1. Genetic predisposition
  • Patients with severe cystic acne often have a positive family history of acne of similar severity.
  • Identical twins have greater concordance of severity of acne.
2. Diet
  • Some recent studies have incriminated a high glycemic diet.
  • Nuts, oily foods, chocolates, an aerated drinks increases acne.
3. Cosmetics
  • Acne is seen in women who use oil-based cosmetics for long period of time.
  • Acne often follows facial massage.
4. Menstrual cycle
  • About 70% of the female patients complain of premenstrual aggravation of acne, probably related to premenstrual edema of the pilosebaseous duct.
5. Psychological factors
  • Severe acne is related to increased anger and anxiety.

Clinical Features

Morphology
  • Most patients with severe acne have a greasy skin with patulous follicular openings (pores).
  • Eruption is polymorphic, characterized by comedones, papules, pustules, nodules, and cysts, all seen in the same patient at the same time.
  • Comedones: are the pathognomonic lesions of acne vulgaris. Two main types of comedones recognized are: 1. Open comedones (black heads): are due to plugging of the pilosebaceous orifice by keratin and sebum on the skin surface. 2. Closed comedones (white heads): are due to keratin and sebum accretions plugging pilosebaseous ducts below the skin surface. Some closed comedones are deep seated (submarine comedones) and are best seen by stretching the skin.
  • Scars: Acne scars can be: 1. Depressed scars: Ice pick scars, Box car scars, Rolling scars. 2. Hypertrophic and keloidal scars.
Sites of predilection
  • Lesions are seen predominantly on the face (foreheads, cheeks, and chin), shoulders, upper chest, and back.
  • If acne-like lesions occurs at unusual sites, suspect an acneiform eruption due to drugs or occupation acne.

Associations

1. Seborrhea: Greasiness of face and patulous folicular openings.
2. Features of hyperandrogenism:
  • Like hirsutism, virilism, irregular periods, and weight gain may be present in some women
  • Such patients need to be investigated for androgen secreting pathology like polycystic ovary syndrome.

Varients

1. Acne conglobata
  • A severe form of acne, characterized by intercommunicating abscesses, cysts, and sinuses loaded with serosanguinous fluid or pus.
  • Comedones are typically multiporous.
  • Lesions take months to heal and on healing leave behind deep pitted or hypertrophic scars, joined by keloidal bridges.
  • Lesions are not only severe but also more extensive and may be associated with follicular occlusion syndrome.
2. Occupational acne
  • Caused by exposure to industrial chemicals like tar, chlorinated hydrocarbons and cutting oils.
  • Lesions are predominantly comedones, though sometimes inflammatory cystic lesions may be present.
3. Cosmetic acne
  • Eruption frequently seen in women using cosmetics, especially oil-based ones.
  • Almost always comedones.
  • Lesions frequently on the chin.
4. Drug-induced acne
  • Steroid, androgens, anabolic steroids, oral contraceptives, antitubercular drugs, iodides, bromides and anticonvulsants can cause an acneiform eruption.
  • Lesions are monomorphic, consisting of papules and sometimes pustules. Comedions and scarring are unusual, especially when induced by steroids.
  • Trunk especially back; face may be involved.
5. Infantile acne
  • Due to presence of maternal hormones in the child.
  • May present at birth and may last for up to 3 years.
  • Lesions similar to those of adolescent.
6. Late onset acne
  • Acne with onset after 25 years of age.
  • Predominantly women.
  • Presents as deep seated, persistent lesions on lower half of face.
  • Exclude underlying androgen secreting pathology, especially polycystic ovarian syndrome.
7. Acne fulminans
  • Acute onset
  • Presents as crusted, ulcerated lesions
  • Associated with fever, myalgia and arthralgia.
8. Acne with facial massage
  • Facial massage may be followed (3-6 weeks later) by an acneiform eruption in about 30% of patients.
  • Indolent deep seated nodules with very few comedones. Heal with hyperpigmentation after several weeks.
  • Predominantly on cheeks, along the mandible. Less on chin.

Investigations

  • No investigations are required for routine management of acne vulgaris.
  • In women, who have late-onset acne associated with hirsutism, virilization and menstrual irregularities, investigations to exclude an androgen secreting pathology (polycystic ovaries) need to be done.

Diagnosis

Points for diagnosis
Diagnosis is based on:
  • Adolescent patient.
  • Background skin of face is greasy with prominent follicular openings.
  • Polymorphic eruption of papules, pustules, nodules, and cysts; lesions heal with typical scarring.
  • Presence of comedones.
  • Typical distribution: face, shoulders, upper part of trunk and chest.

Differential diagnosis

  • Rosacea
  • Folliculitis

Acne vulgaris Treatment

Treatment modalities available include:
  • General measures.
  • Topical therapy.
  • Systemic therapy.
  • Physical therapy.
1. General measures
  • Local hygiene: regular gentle cleansing with soap and water should encouraged. Application of oil-based cosmetics should be avoided as they aggravate acne, but water based cosmetics can be used.
  • Diet: Some dermatologists have begun to restrict high glycemic diets.
  • Stress: Acne induces stress and this needs to be handled. Stress itself may induce acne.
2. Topical therapy

A. Retinoids

Preparations available:
  • Drugs: Retinoic acid (RA), adapalene, isoretinion and tazarotene.
Indications:
  • In active disease: effective against both comedones and inflammatory acne.
  • For maintenance: reduces formation of microcomedo.
Mode of action:
  • Specially effective against comedones because it normalizes follicular keratinization by: Increasing epidermal cell turnover and increasing dehiscence of stratum corneum.
  • Also effective against inflammatory lesions, especially adapalene.
Clinical use:
  • Start with lowest concentration; gradually introducing higher concentration over period of weeks.
  • Use only at night, it can cause photosensitivity. Adapalene can be used during day.
  • Should be applied to all acne-prone area.
  • Excessive dryness is to be avoided to ensure compliance.
  • Can be combined with topical antibiotics.
Side effects:
  • Irritation: More with tazarotene> retinoic acid> adapalene.
  • Photosensitivity: frequent with RA, so use at night.
B. Benzoyl peroxide (BP)

Mode of action: 

  • BP is a powerful antimicrobial, decresing population of P. acnes.
  • Also has anti-inflammatory effect.
Indications:
  • Mild acne, as stand alone therapy
  • Always to antibiotic therapy, to reduce resistance.
  • Moderate-severe acne as topical adjuvant to systemic therapy.
Clinical use:
  • Used in both inflammatory and non-inflammatory acne.
  • Initially used in lower concentration for short duration (1-2 h); increases over period of time to higher concentration and over longer periods of time.
Side effects:
  • Irritation.
  • Bleaching of hair.
C. Topical antibiotics
  • Most frequently used topical antibiotics are clindamycin (1-2%) and erythromycin (2-4%).
Mode of action: Suppress P.acnes and its mediators of inflammation and so are more effective against inflammatory acne.

Clinical use: Useful in inflammatory acne but must always be combined with topical retinoic acid or benzoyl peroxide.

Side effects: Resistance of microorganisms to antibiotics is a major problem, so should be combined with topical retinoids or benzoyl peroxide.

Other agents

  • Alpha-hydroxy acids: e.g., glycolic acid (6-12%)
  • Azelaic acid (10-20%): Also reduces postacne hyperpigmentation.
3. Systemic treatment

A. Antibiotics

Drugs used: 
  • Doxycycline and minocycline are frequently used. Less frequently, erythromycin and azithromycin.
Mode of action:
  • Inhibits growth of P. acnes and its metabolism.
  • Direct anti-inflammatory effect.
Indications:
  • Moderately severe acne
  • Mild acne, if acne is affecting patient's quality of life.
  • Severe acne, if oral retinoids cannot be used.
Regimens:
  • Tetracycline (1g), doxycycline (100 mg), minocycline (100 mg), Erythromycin (1g) daily. Or azithromycin (250 mg), 3-4 times a week  (up to 3-6 months).
  • Tetracycline and doxycycline should be taken empty stomach. Absorption decrease by milk, antacids and metal salts.
  • Oral antibiotics should always be combined with topical agents.
  • Minocycline concentrates in sebaceous glands and is more effective than tetracycine.
Adverse events:
  • Gastrointestinal side effects: include nausea.
  • Cutaneous side effects: Long term administration of minocycline may cause grayish pigmentation of skin, mucosae, and nails.
  • Teratogenicity: tetracycline should be avoided in pregnant women and in children under 8 years of age.
  • Infections: vaginal candidiasis.
  • Resistance of P. acnes to antibiotics: more frequent with macrolides, so their use should be limited.

B. Hormones

Mode of action: 
  • Antiandrogens act by decreasing sebum secretion rate.
Indications: Only in females.
  • Late onset acne.
  • Women with menstrual irregularities.
Treatment schedules: Need to be used for long periods of time (6-24 months)
  • Cyproterone acetate: is available as combination of 2 mg cyproterone acetate and 35 microgram estradiol.
  • Spironolactone: 50-100 mg daily.
C. Isotretinoin
  • Isotretinoin (13-cis-retinoic acid), a retinoid has revolutionized management of severe intractable acne.
Mode of action:
  • Inhibits sebum secretion
  • Decreases P. acne counts
  • Reduces inflammation.
Indications: 
  • Severe acne, acne conglobata.
  • Moderately severe acne not responds to conventional therapy.
  • Any grade of acne which is causing distress.
Treatment schedule:
  • Used in a dose of 0.5-1 mg/kg body weight daily.
  • Higher dose required for truncal acne.
  • Is given for the period of 12-16 weeks.
Side effects:
  • Dryness of eyes, dry skin, cheilitis, hair loss and nose bleeds.
  • Should not be used in pregnant women because of teratogenicity.
  • Myalgia, vertebral hyperostosis and altered night vision.
  • Patient should not to donate blood during treatment and for 1 month thereafter.
  • Pseudotumor cerebri

4. Physical therapy

Intralesional corticosteroids
  • Active disease: Inj. of long acting steroid (triamcinolone acetonide 10 mg/ml) into nodules results in dramatic resolution of lesions.
  • Hypertrophic scars: Inj. of long acting steroid (triamcinolone acetonide 10 mg/ml) into recalcitrant hypertrophic scars/ keloids result in slow resolution of lesions.
Cryotherapy
  • Freezing with liquid nitrogen hasten resolution of recalcitrant nodulocystic lesions.
  • Scars also responds.
Laser thereapy
  • Laser skin resurfacing has been used to treat acne scars.
  • Laser used is carbon dioxide laser.
Photodynamic treatment
  • Uses: Red light and a photosensitizer like aminolevulinic acid (ALA)
  • Response: moderate
Dermabrasion
  • Superficial dermabrasion helps in reducing scars
  • Occasionally leaves behind unsightly hyperpigmentation and may cause photosensitivity.
Fillers
  • Injection of fillers to augment tissue defects are of limited benefit. 
  • Treatment is expensive and needs to be repeat every 6 months.

Comments

Popular posts from this blog

Mechanism of Normal Labor

  Mechanism of normal labor Definition: The series of movements that occur on the head in the process of adaptation during its journey through the pelvis is called mechanism of labor. Mechanism:   In normal labor, the head enters the brim more commonly through the available transverse diameter (70%) and to the lesser extent through one of the oblique diameters. The position is either occipitolateral or oblique occipitoanterior. Left occipitoanterior is more common than right occipitoanterior as the left oblique diameter is encroached by the rectum. The engaging anteroposterior diameter of the head is either suboccipitobregmatic 9.5 cm or in slight deflexion-the suboccipitofrontal 10 cm. The engaging transverse diameter is biparietal 9.5 cm. As the occipitolateral position is most common, the mechanism of the labor in such position will be described. The principal movements are: Engagement Descent Flexion Internal rotation  Crowning Extension Restitution External rotation Expulsion of

Alopecia (Baldness)

 Alopecia: causes, diagnose, and treatment Alopecia : Alopecia means loss of hair. There are two types of alopecia. Non-cicatricial alopecia Cicatricial alopecia Difference between cicatricial and noncicatricial alopecia Alopecia Areata (AA) Etiology The pathogenesis of AA is uncertain and following factors are incriminated: Immunological factors: AA is considered an immunological disease because of: Association of AA with other auto-immune diseases (auto-immune thyroid disease, pernicious anemia, vitiligo, and atopy) Cytokines produced by dermal papillae in lesions not only attract lymphocytes to perifollicular region but also stimulate them to multiply. As opposed to normal hairs, strong major histocompatibility complex (class 1 and class 2) immunoreactivity found in affected follicles. 2. Genetic factors: AA may be present in some families, so it may have a genetic basis. 3. Emotional factors: In some patients, AA is precipitated by emotional stress. Epidemiology     Prevalence:   A

Hereditory spherocytosis

• This is the abnormality of red blood cells. • This is usually inherited as an AUTOSOMAL DOMINANT condition. • The most common abnormalities are deficiencies of BETA SPECTRIN or ANKYRIN. • Most cases are associated with an asymptomatic compensated chronic haemolytic state with spherocutes present on the blood film, a reticulocytosis and mild hyperbilirubinaemia. • Pigment GALLSTONES are present in up to 50% of patients and may cause chlolecystitis. The clinical course may be complicated by crisis : • A HAEMOLYTIC CRISIS occurs when the severity of haemolysis increases. • A MEGALOBLASTIC CRISIS follows the development of folate deficiency. • An APLASTIC CRISIS occurs in association with PARVOVIRUS B19 infection. Investigations • The blood film will show spherocytes but the direct Coombs test is negative, excluding immune haemolysis. • An OSMOTIC FRAGILITY TEST may show increased sensitivity to lysis in hypotonic saline solutions but is limited by lack of sensitivity and specificity. •